Larvol Delta - COLUMBUSAMD-Efficacy-and-Safety-of-the-Biosimilar-Ranibizumab-FYB201-in-Comparison-to-Lucentis-in-Patients-With-Neovascular-Agerelated-Macular-Degeneration

FYB201 (ranibizumab biosimilar) - Amneal, Formycon

http://clinicaltrials.gov/ct2/show/NCT02611778

Jan 29, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next